MetaVia MTVA
NASDAQ MTVA
$1.46 +0.02 (+1.39%)
At close: Aug 21, 2026 · 4:00 PM EDT

MetaVia (MTVA) Operating Leases (2019 - 2026)

MetaVia's (MTVA) quarterly Operating Leases came in at $142000.0 in Q4 2025, up 144.83% YoY from $58000.0 in Q4 2024, and up 846.67% on a QoQ basis from $15000.0 in Q2 2025.

MetaVia (MTVA) Operating Leases (2019 - 2026) Analysis & Trends

MetaVia (MTVA) has 6 years of Operating Leases data on file, last reported at $142000.0 in Q4 2025.

  • Quarterly Operating Leases rose 144.83% year-over-year to $142000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $142000.0 (up 144.83% YoY) and the FY2025 annual result came in at $142000.0, up 144.83% from the prior year.
  • Operating Leases climbed to $142000.0 in Q4 2025, from $15000.0 in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $218000.0 in Q3 2023 to a low of $15000.0 in Q2 2025.
  • A 4-year average of $90000.0 and a median of $79000.0 in 2024 frame the typical range for Operating Leases.
  • The widest YoY moves for Operating Leases: up 144.83% in 2025, down 84.69% in 2025.
  • Tracing MTVA's Operating Leases over 4 years: stood at $45000.0 in 2021, then soared by 202.22% to $136000.0 in 2023, then slumped by 57.35% to $58000.0 in 2024, then jumped by 144.83% to $142000.0 in 2025.
  • The last three Operating Leases figures came in at $142000.0 (Q4 2025), $15000.0 (Q2 2025), and $37000.0 (Q1 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 MetaVia 8.72 Mn -3.92 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2026 103,000.00
Dec 31, 2025 142,000.00
Jun 30, 2025 15,000.00
Mar 31, 2025 37,000.00
Dec 31, 2024 58,000.00
Sep 30, 2024 79,000.00
Jun 30, 2024 98,000.00
Mar 31, 2024 117,000.00
Dec 31, 2023 136,000.00
Sep 30, 2023 218,000.00
Dec 31, 2021 45,000.00
Sep 30, 2021 77,000.00
Jun 30, 2021 83,000.00
Mar 31, 2021 65,000.00
Dec 31, 2020 70,000.00
Dec 31, 2019 94,000.00
Sep 30, 2019 106,000.00